title: Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
abstract: BACKGROUND
  Small-cell lung carcinoma (SCLC) is a highly malignant tumour of a somewhat distinctive cell type. The aim of this study was to determine the immunocytochemical profile of tumor cells and lymphoid cell in SCLC pleural fluids.
  
  
  METHODS
  Nine cases of malignant pleural fluids of SCLC were studied using cell block preparation. In pleural effusions cytologically proven to be malignant in 9 patients with SCLC, the immunocytological features of tumor cells, together with the determination of lymphocytic subsets were documented.
  
  
  RESULTS
  In all 9 cases, tumor cells reacted with neuron-specific enolase (NSE) (100%), whereas in 6 of 9 cases (66,66%) tumor cell expressed synaptophysin, thyroid transciption factor-1 (TTF-1) and chromogranin A antigens. Phenotyping of the lymphocytes revealed in the majority of cases an expression of CD3 and CD4 antigens (8 and 7 cases, respectively) in contrast to CD8 and CD20 expression (1 and 1 case, respectively).
  
  
  CONCLUSIONS
  The reactivity pattern of the tumor cells with the markers used in our study is a specific for SCLC. No significant difference in the distribution of lymphocytic subpopulations is observed in correlation with other malignant and no malignant processes involving the pleural cavity.
authors.affiliation: Department of Cytology, Regional Hospital of Alexandroupolis, Greece.
authors.forename: D
authors.initials: D
authors.lastname: Tamiolakis
authors.forename: N
authors.initials: N
authors.lastname: Papadopoulos
authors.forename: A
authors.initials: A
authors.lastname: Cheva
authors.forename: M
authors.initials: M
authors.lastname: Lambropoulou
authors.forename: A
authors.initials: A
authors.lastname: Kotini
authors.forename: D
authors.initials: D
authors.lastname: Mikroulis
authors.forename: V
authors.initials: V
authors.lastname: Didilis
authors.forename: N
authors.initials: N
authors.lastname: Bitzikas
authors.forename: G
authors.initials: G
authors.lastname: Bougioukas
mesh_terms: D015703:Antigens, CD / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000737:chemistry*; D053379:Chromogranin A; D002864:Chromogranins / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000737:chemistry*; D009363:Neoplasm Proteins / Q000032:analysis*; D009687:Nuclear Proteins / Q000032:analysis; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D016066:Pleural Effusion, Malignant / Q000737:chemistry*; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors / Q000032:analysis
chemical_list: D015703:Antigens, CD; D053379:Chromogranin A; D002864:Chromogranins; C000614412:NKX2-1 protein, human; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D000074482:Thyroid Nuclear Factor 1; D014157:Transcription Factors; D010751:Phosphopyruvate Hydratase